---
figid: PMC9077075__ajcr0012-1686-f10
pmcid: PMC9077075
image_filename: ajcr0012-1686-f10.jpg
figure_link: /pmc/articles/PMC9077075/figure/fig10/
number: Figure 10
figure_title: ''
caption: Statistic analysis of anti-tumor drug effects on the mTOR signaling pathway.
  Statistic analysis results show the relative folds of HIN1, phosphorylation of mTOR
  (p-mTOR), phosphorylation of Rictor (p-Rictor), phosphorylation of AKT (p-AKT) (Thr308),
  and p-AKT (Ser473) in ES2 cells, ES2 tumorspheres (TS), ES2TR160 cells, and ES2TR160
  TS treated with 5-aza-dC, RAD001, or 5-aza-dC combined with RAD001.
article_title: Everolimus combined with 5-aza-2-deoxycytidine generated potent anti-tumor
  effects on ovarian clear cell cancer stem-like/spheroid cells by inhibiting the
  COL6A3-AKT-mTOR pathway.
citation: Chih-Ming Ho, et al. Am J Cancer Res. 2022;12(4):1686-1706.
year: '2022'

doi: ''
journal_title: American Journal of Cancer Research
journal_nlm_ta: Am J Cancer Res
publisher_name: e-Century Publishing Corporation

keywords:
- 5-aza-2-deoxycytidine
- everolimus
- ovarian cancer
- ovarian clear cell
- cancer stem cells
- COL6A3-AKT-mTOR pathway

---
